Be realistic, responsive and transparent: how to engage underperforming sites
Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that was the takeaway from …
Being realistic, responsive and transparent is key in engaging unresponsive and underperforming clinical trial sites; that was the takeaway from …
The UK government is pledging £82.6m ($102.2m) in research funding to back artificial intelligence (AI) companies developing technologies to accelerate …
At a time when the US is pausing much of its international aid initiatives, the World Health Organization (WHO) and …
Grace Therapeutics has announced the initial closure of a financing round, securing almost $15m, to fund the pre-commercial development of …
Eli Lilly is paying up to $630m for a Phase I metabolic-associated steatohepatitis (MASH) candidate from South Korea-based biotech OliX …
Novartis has agreed to acquire Boston-based clinical-stage biopharmaceutical company Anthos Therapeutics for an upfront payment of $925m. The transaction includes $2.15bn …
The obesity market is growing at an unprecedented rate following the entrance of GLP-1 receptor agonists. In a recently published …
Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for the Simponi (golimumab) biosimilar, BAT2506 in the …
Researchers in the UK are calling for better inclusion of rare diseases in public health strategies, including pandemic planning, vaccination …
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application (NDA) for Stapokibart to treat seasonal …
A 66-year-old man has become the fourth person in the world to receive a genetically edited pig kidney transplant, performed …
As the Philadelphia Eagles romped to victory against the Kansas City Chiefs in the Super Bowl LIX, the eyes of …
Eton Pharmaceuticals has secured a patent from the US Patent and Trademark Office (USPTO) for its ET-600 product candidate’s desmopressin …
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in conjunction …
US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a …